Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Sestak

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Cancer Management and Research|November 8, 2014
Preventative therapies for healthy women at high risk of breast cancerIvana Sestak
Current Opinion in Oncology|October 10, 2018
Risk stratification in early breast cancer in premenopausal and postmenopausal women: integrating genomic assays with clinicopathological featuresIvana Sestak
Breast Care (Basel, Switzerland)|August 9, 2017
Identifying Biomarkers to Select Patients with Early Breast Cancer Suitable for Extended Adjuvant Endocrine TherapyIvana Sestak
Current Opinion in Obstetrics & Gynecology|December 18, 2014
Update on breast cancer risk prediction and preventionIvana Sestak, Jack Cuzick
Current Oncology Reports|September 14, 2012
Preventive therapy for breast cancerIvana Sestak, Jack Cuzick
Breast Cancer Research : BCR|April 8, 2015
Markers for the identification of late breast cancer recurrenceIvana Sestak, Jack Cuzick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trialIvana Sestak, Francisco Sapunar, Jack Cuzick
Breast (Edinburgh, Scotland)|August 11, 2015
Impact of preventive therapy on the risk of breast cancer among women with benign breast diseaseJack Cuzick, Ivana Sestak, Mangesh A Thorat
Breast Cancer Research and Treatment|November 22, 2020
Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancerJuliet Richman, Alistair Ring, Mitch Dowsett, et al.
The Lancet. Oncology|November 4, 2008
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trialJack Cuzick, Ivana Sestak, David Cella, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Cancer Management and Research|November 8, 2014
Preventative therapies for healthy women at high risk of breast cancerIvana Sestak
Current Opinion in Oncology|October 10, 2018
Risk stratification in early breast cancer in premenopausal and postmenopausal women: integrating genomic assays with clinicopathological featuresIvana Sestak
Breast Care (Basel, Switzerland)|August 9, 2017
Identifying Biomarkers to Select Patients with Early Breast Cancer Suitable for Extended Adjuvant Endocrine TherapyIvana Sestak
Current Opinion in Obstetrics & Gynecology|December 18, 2014
Update on breast cancer risk prediction and preventionIvana Sestak, Jack Cuzick
Current Oncology Reports|September 14, 2012
Preventive therapy for breast cancerIvana Sestak, Jack Cuzick
Breast Cancer Research : BCR|April 8, 2015
Markers for the identification of late breast cancer recurrenceIvana Sestak, Jack Cuzick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trialIvana Sestak, Francisco Sapunar, Jack Cuzick
Breast (Edinburgh, Scotland)|August 11, 2015
Impact of preventive therapy on the risk of breast cancer among women with benign breast diseaseJack Cuzick, Ivana Sestak, Mangesh A Thorat
Breast Cancer Research and Treatment|November 22, 2020
Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancerJuliet Richman, Alistair Ring, Mitch Dowsett, et al.
The Lancet. Oncology|November 4, 2008
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trialJack Cuzick, Ivana Sestak, David Cella, et al.
Pageof 7